Free Cash Flow

With a near-unanimous vote, shareholders have greenlit the creation of a North American precious metals giant, setting the stage for a major industry shift.

With DOE safety validation for its Mark-0 reactor, Antares accelerates its push to power U.S. defense and space missions with advanced nuclear energy.

With over $2B in acquisitions and $1B in new projects, Clarion is aggressively reshaping its portfolio. Is industrial real estate the ultimate safe haven?

Nuvve's new partnership with Capture Energy for modular battery systems aims to accelerate its V2G and grid services expansion across the Nordics.

A major shift in defense contracting, fueled by a $1.5T private capital wave, demands field-ready tech. Companies that can deliver are poised to win.

A worker's death at Serabi Gold's Coringa mine puts the company's ambitious growth plans and safety record under intense scrutiny in Brazil.

A hefty Q4 loss driven by a renewable diesel reversal and plant issues overshadows full-year profit, signaling a major strategic shift for 2026.

Onity Group is raising $150 million via high-yield notes, a strategic but risky move to refinance debt and fund growth amid a complex financial backdrop.

Offshore driller Noble Corp. secures $1.3 billion in new contracts, entering Norway's harsh environment market and signaling a major industry upswing.

With 99% shareholder approval, Ovintiv’s C$3.8B acquisition of NuVista is nearly complete, awaiting only final regulatory clearance for the major deal.

With strong Q1 momentum, Standex faces a complex market. Its upcoming Q2 results will offer key insights into global manufacturing and corporate strategy.

The airline industry is set for a record $41B profit in 2026, but a severe aircraft shortage and a new growth axis in the East are reshaping the skies.

The industrial giant declared its 303rd consecutive quarterly dividend, cementing its status as a top-tier investment for reliable income.

Appointments to the influential Nashville Health Care Council signal a major validation for Monogram Health's disruptive in-home chronic care model.

As PUDO Inc. preps its Q3 results, all eyes are on the independent parcel network's growth and its strategy to rival logistics giants in a booming market.

Amid a year of steep losses and strategic upheaval, JELD-WEN's upcoming full-year results will offer a critical look into the health of the global building industry.

As founder Patrick Gruber steps back, incoming CEO Paul Bloom is set to commercialize Gevo's green tech, focusing on profitability and its ambitious SAF goals.

As automakers enforce strict digital standards, DATAMYTE's new platform helps suppliers ditch spreadsheets for a connected, AI-driven quality system.

With two major trial results looming, Zura Bio appoints Sandeep Kulkarni, who led Tourmaline to a Novartis sale, to navigate its high-stakes future.

As Cellebrite prepares to report its 2025 results, all eyes are on its performance as a key indicator for the future of AI in law enforcement and public safety.